Form 8-K - Current report:
SEC Accession No. 0000950170-25-084385
Filing Date
2025-06-10
Accepted
2025-06-10 16:37:05
Documents
10
Period of Report
2025-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K nuvl-20250609.htm   iXBRL 8-K 43916
  Complete submission text file 0000950170-25-084385.txt   158096

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvl-20250609.xsd EX-101.SCH 31920
12 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20250609_htm.xml XML 4703
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 251037648
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)